DarioHealth Corp.

NASDAQ:DRIO

0.9 (USD) • At close September 18, 2024
Bedrijfsnaam DarioHealth Corp.
Symbool DRIO
Munteenheid USD
Prijs 1
Beurswaarde 30,025,297
Dividendpercentage 0%
52-weken bereik 0.68 - 3.49
Industrie Diagnostics & Research
Sector Healthcare
CEO Mr. Erez Raphael
Website https://www.mydario.com

An error occurred while fetching data.

Over DarioHealth Corp.

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK

Vergelijkbare Aandelen

Assertio Holdings, Inc. logo

Assertio Holdings, Inc.

ASRT

1.35 USD

IO Biotech, Inc. logo

IO Biotech, Inc.

IOBT

1.19 USD

Ikena Oncology, Inc. logo

Ikena Oncology, Inc.

IKNA

1.71 USD

AVITA Medical, Inc. logo

AVITA Medical, Inc.

RCEL

9.96 USD

Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc.

CTXR

0.548 USD

Sol-Gel Technologies Ltd. logo

Sol-Gel Technologies Ltd.

SLGL

0.702 USD

Ovid Therapeutics Inc. logo

Ovid Therapeutics Inc.

OVID

1.17 USD

ProPhase Labs, Inc. logo

ProPhase Labs, Inc.

PRPH

2.51 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)